|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Fostamatinib disodium>> Market Analysis Reports |
Market Analysis Reports of Fostamatinib disodium |
|
Global Market Report of Fostamatinib disodium (CAS 1025687-58-4) December 2024 CAS 914295-16-2 Fostamatinib disodium salt hexahydrate Chemical Report & Database ... Fostamatinib disodium salt hexahydrate Chemical Report & Database This Fostamatinib disodium salt ... Fostamatinib disodium salt hexahydrate World Consumption Report & Database definitions: Name: Fostamatinib disodium salt hexahydrate: Fostamatinib-disodium ... Rigel Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... . The agreement includes a license of rights to fostamatinib disodium, or R788, its late-stage investigational ... Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H2 2018 Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H2 2018 SUMMARY Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) pipeline Target constitutes close to 26 molecules ... Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H1 2018 Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H1 2018 SUMMARY Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Spleen tyrosine kinase, also known as Syk, is ... Therapy Trends: Rheumatoid Arthritis -- KOL Insight and Consensus Outlook Modules What the future holds Over the next few years, the global Rheumatoid Arthritis (RA) market is expected to grow from $16.5 billion in 2011 to $23.4 billion in 2016. This expansion of the market will be driven by continued use of existing RA products and ... Therapy Trends: Rheumatoid Arthritis -- Consensus Outlook Module Analyse the latest global RA market players and products, and start mapping your future market parameters with Therapy Trends’ Consensus Outlook: Rheumatoid Arthritis, which includes the following comprehensive resources: An in-depth 5-year forecast report ... Global Immune Thrombocytopenic Purpura Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028 ... segment by Type, covers Eltrombopag Olamine Fostamatinib Disodium GL-2045 Avatrombopag BI-655064 Others Market ... Warm Autoimmune Hemolytic Anemia (WAIHA) – Pipeline Insight, 2020 ... Hemolytic Anemia Emerging Drugs Fostamatinib: Rigel Pharmaceuticals Rigel Pharmaceuticals is ... the safety and efficacy of fostamatinib disodium in the treatment of Warm Antibody ... this study is to evaluate whether fostamatinib is safe and effective in the ... Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or ... Immune Thrombocytopenic Purpura Therapeutics Market, Global Outlook and Forecast 2022-2028 ... Percentages, by Type, 2021 (%) Eltrombopag Olamine Fostamatinib Disodium GL-2045 Avatrombopag BI-655064 Others Global ... Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide ... Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2019 Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Thrombocytopenic Purpura - Pipeline Review, H2 2019, ... Therapy Trends: Rheumatoid Arthritis -- KOL Insight Module Therapy Trends KOL Insight: Rheumatoid Arthritis analyses the current and predicted key issues, clinical advances and late-stage pipeline products in the international and US RA markets. KOL Insight gives you qualitative, inside information from exclusive ... Immune thrombocytopenia (ITP) - Pipeline Review - 2019 ... ) Privigen Rhophylac Doptelet (Avatrombopag) Tavalisse (fostamatinib disodium hexahydrate) Rituximab Promacta (eltrombopag) Gammaplex ... 2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ... , Fluvoxamine, Folic Acid, Fondapariniux, Formoterol, fostamatinib disodium hexahydrate, FT516, Galidesivir, Garadacimab, Gemtuzumab ... COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update ... , Fluvoxamine, Folic Acid, Fondapariniux, Formoterol, fostamatinib disodium hexahydrate, FT516, Galidesivir, Garadacimab, Gemtuzumab ... 2023-2028 Global and Regional Immune Thrombocytopenic Purpura Therapeutics Industry Status and Prospects Professional Market Research Report Standard Version ... AG Pfizer Inc. By Types: Eltrombopag Olamine Fostamatinib Disodium GL-2045 Avatrombopag BI-655064 Others By Applications ... Global Immune Thrombocytopenic Purpura Therapeutics Market Research Report 2024(Status and Outlook) ... . Market Segmentation (by Type) Eltrombopag Olamine Fostamatinib Disodium GL-2045 Avatrombopag BI-655064 Others Market ... Rigel Pharmaceuticals Inc (RIGL) - Financial and Strategic SWOT Analysis Review ... product, the US FDA approved Tavalisse (fostamatinib disodium hexahydrate), is an oral spleen tyrosine kinase ... immune thrombocytopenia. Rigel is also evaluating Fostamatinib for autoimmune hemolytic anemia and ... |